VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,632,334 | -79.1% | 1,303,781 | -68.0% | 0.00% | -100.0% |
| Q2 2023 | $26,891,391 | -13.0% | 4,080,636 | -10.4% | 0.00% | -50.0% |
| Q1 2023 | $30,907,482 | -43.9% | 4,551,912 | -38.9% | 0.00% | 0.0% |
| Q4 2022 | $55,096,854 | +51.3% | 7,455,596 | +102.3% | 0.00% | 0.0% |
| Q3 2022 | $36,411,000 | -10.1% | 3,685,351 | -0.8% | 0.00% | 0.0% |
| Q2 2022 | $40,504,000 | -11.9% | 3,715,925 | -8.5% | 0.00% | 0.0% |
| Q1 2022 | $45,956,000 | -12.0% | 4,063,298 | +22.1% | 0.00% | 0.0% |
| Q4 2021 | $52,207,000 | -10.4% | 3,327,433 | -2.1% | 0.00% | -33.3% |
| Q3 2021 | $58,242,000 | -14.4% | 3,398,042 | +7.5% | 0.00% | -25.0% |
| Q2 2021 | $68,004,000 | +36.7% | 3,161,509 | -4.6% | 0.00% | +33.3% |
| Q1 2021 | $49,751,000 | +18.2% | 3,312,339 | +3.4% | 0.00% | 0.0% |
| Q4 2020 | $42,099,000 | +28.7% | 3,203,904 | -5.4% | 0.00% | +50.0% |
| Q3 2020 | $32,702,000 | -22.3% | 3,385,334 | -8.0% | 0.00% | -33.3% |
| Q2 2020 | $42,083,000 | +43.2% | 3,678,612 | +29.7% | 0.00% | 0.0% |
| Q1 2020 | $29,380,000 | -29.3% | 2,835,916 | +11.9% | 0.00% | 0.0% |
| Q4 2019 | $41,583,000 | +9.3% | 2,534,020 | -11.6% | 0.00% | 0.0% |
| Q3 2019 | $38,058,000 | -10.0% | 2,865,837 | -4.5% | 0.00% | 0.0% |
| Q2 2019 | $42,281,000 | -37.4% | 3,000,816 | -18.3% | 0.00% | -40.0% |
| Q1 2019 | $67,580,000 | +4.6% | 3,672,809 | +48.6% | 0.01% | -16.7% |
| Q4 2018 | $64,592,000 | +11.2% | 2,471,955 | -2.4% | 0.01% | +50.0% |
| Q3 2018 | $58,100,000 | +40.3% | 2,531,741 | +16.5% | 0.00% | +33.3% |
| Q2 2018 | $41,399,000 | +30.4% | 2,173,011 | +15.3% | 0.00% | 0.0% |
| Q1 2018 | $31,747,000 | -2.2% | 1,884,090 | -11.8% | 0.00% | 0.0% |
| Q4 2017 | $32,456,000 | +10.0% | 2,135,227 | +29.5% | 0.00% | 0.0% |
| Q3 2017 | $29,507,000 | +11.9% | 1,648,632 | +1.9% | 0.00% | +50.0% |
| Q2 2017 | $26,380,000 | +19.9% | 1,618,485 | +2.9% | 0.00% | 0.0% |
| Q1 2017 | $22,007,000 | -21.2% | 1,572,186 | -10.2% | 0.00% | -33.3% |
| Q4 2016 | $27,935,000 | +21.9% | 1,751,605 | +27.2% | 0.00% | +50.0% |
| Q3 2016 | $22,921,000 | +59.3% | 1,377,510 | +7.2% | 0.00% | 0.0% |
| Q2 2016 | $14,385,000 | +15.6% | 1,285,054 | -13.7% | 0.00% | +100.0% |
| Q1 2016 | $12,442,000 | -20.9% | 1,488,367 | -11.9% | 0.00% | -50.0% |
| Q4 2015 | $15,721,000 | -44.0% | 1,688,766 | -32.1% | 0.00% | -33.3% |
| Q3 2015 | $28,066,000 | -13.9% | 2,488,179 | -3.2% | 0.00% | 0.0% |
| Q2 2015 | $32,610,000 | +30.6% | 2,569,617 | -4.3% | 0.00% | 0.0% |
| Q1 2015 | $24,974,000 | -7.1% | 2,685,595 | +43.0% | 0.00% | 0.0% |
| Q4 2014 | $26,888,000 | +42.9% | 1,877,584 | +3.6% | 0.00% | +50.0% |
| Q3 2014 | $18,811,000 | -25.1% | 1,812,334 | +16.8% | 0.00% | -33.3% |
| Q2 2014 | $25,110,000 | -0.6% | 1,551,918 | -0.2% | 0.00% | 0.0% |
| Q1 2014 | $25,262,000 | +180.9% | 1,554,430 | +41.5% | 0.00% | +200.0% |
| Q4 2013 | $8,994,000 | +56.1% | 1,098,628 | +109.3% | 0.00% | 0.0% |
| Q3 2013 | $5,762,000 | +39.7% | 524,832 | +2.8% | 0.00% | 0.0% |
| Q2 2013 | $4,125,000 | – | 510,518 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |